Journal
MABS
Volume 2, Issue 4, Pages 361-364Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/mabs.12461
Keywords
monoclonal antibody; therapeutic products; bispecific antibodies; antibody conjugates
Categories
Ask authors/readers for more resources
With the rapid growth of monoclonal antibody-based products, new technologies have emerged for creating modified forms of antibodies, including fragments, conjugates and multi-specific antibodies. We created a database of 450 therapeutic antibodies in development to determine which technologies and indications will constitute the next generation of antibody products. We conclude that the antibodies of the future will closely resemble the antibodies that have already been approved for commercial sale.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available